MAOIS AND REBOXETINE
No data seem to be available about the concurrent use of reboxetine with MAOIs. However, the manufacturers predict that a hypertensive reaction is possible.
Concurrent use should be avoided. With other drugs that interact in the manner predicted it is usually advised that concurrent use should also be avoided for 2 weeks after the MAOI has been stopped.
Concurrent use should be avoided. With other drugs that interact in the manner predicted it is usually advised that concurrent use should also be avoided for 2 weeks after the MAOI has been stopped.